H. Lundbeck A/s
Clinical trials sponsored by H. Lundbeck A/s, explained in plain language.
-
New Parkinson's pill aims to lengthen 'Good ON Time' for patients
Symptom relief Not yet recruitingThis study tests an experimental drug called Lu AF28996 in 150 adults with Parkinson's disease who still have ups and downs in movement control despite their current medications. The goal is to see if adding this drug can increase the hours each day when symptoms are well-control…
Phase: PHASE2 • Sponsor: H. Lundbeck A/S • Aim: Symptom relief
Last updated May 26, 2026 06:43 UTC
-
New Parkinson's drug candidate tested in small chinese trial
Symptom relief Not yet recruitingThis early-stage study tests a new drug called Lu AF28996 in 10 Chinese adults with Parkinson's disease. The main goal is to check the drug's safety and how the body processes it. Participants must have moderate Parkinson's with predictable movement fluctuations. This trial does …
Phase: PHASE1 • Sponsor: H. Lundbeck A/S • Aim: Symptom relief
Last updated May 26, 2026 06:40 UTC